Report overview
This report aims to provide a comprehensive presentation of the global market for Carbapenem-Based Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carbapenem-Based Antibiotics. This report contains market size and forecasts of Carbapenem-Based Antibiotics in global, including the following market information:
Global Carbapenem-Based Antibiotics Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Carbapenem-Based Antibiotics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Meropenem Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Carbapenem-Based Antibiotics include ACS Dobfar S.p.A, Iterum Therapeutics plc, DAEWOONG PHARMACEUTICAL CO.,LTD, Aurobindo Pharma Ltd, Gland Pharma Limited, Merck & Co., Inc., Sumitomo Dainippon Pharma Co., Ltd., Savior Lifetec and Pfizer Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
WE surveyed the Carbapenem-Based Antibiotics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Carbapenem-Based Antibiotics Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Carbapenem-Based Antibiotics Market Segment Percentages, by Type, 2022 (%)
Meropenem
Doripenemu
Imipenem
Tebipenemu
Others
Global Carbapenem-Based Antibiotics Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Carbapenem-Based Antibiotics Market Segment Percentages, by Application, 2022 (%)
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Global Carbapenem-Based Antibiotics Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Carbapenem-Based Antibiotics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Carbapenem-Based Antibiotics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Carbapenem-Based Antibiotics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ACS Dobfar S.p.A
Iterum Therapeutics plc
DAEWOONG PHARMACEUTICAL CO.,LTD
Aurobindo Pharma Ltd
Gland Pharma Limited
Merck & Co., Inc.
Sumitomo Dainippon Pharma Co., Ltd.
Savior Lifetec
Pfizer Inc.
Spero Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Carbapenem-Based Antibiotics, market overview.
Chapter 2: Global Carbapenem-Based Antibiotics market size in revenue.
Chapter 3: Detailed analysis of Carbapenem-Based Antibiotics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Carbapenem-Based Antibiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
